EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Age‐Related Differences in Comorbidities Following Bullous Pemphigoid: A Nationwide Cohort Study

Sille Brændsgaard Nørfjand, Anne Sofie Frølunde, Line Kibsgaard, Rikke Bech, Christian Vestergaard

JEADV Clinical Practice · 30.10.2026

DOI: 10.1002/jvc2.70473 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift JEADV Clinical Practice, online erschienen am 30.10.2026. Verfasst von Sille Brændsgaard Nørfjand und 4 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bullous pemphigoid is associated with several comorbidities; however, the influence of age at diagnosis on these risks remains unclear.

Objectives

To examine age‐related differences in the risk of developing selected comorbidities within a nationwide cohort of patients with bullous pemphigoid.

Methods

We conducted a registry‐based cohort study using a pre‐existing cohort derived from the Danish National Patient Registry. Patients aged ≥ 40 years with a first‐time diagnosis of bullous pemphigoid were stratified into five age groups. Cox proportional hazards regression was used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs), using patients aged 70–79 years as the reference group.

Results

Among patients aged 50–59 years, the risk of type 1 diabetes was significantly increased (HR 2.61, 95% CI 1.15–5.93). Patients aged 60–69 years had a higher risk of type 2 diabetes (HR 1.51, 95% CI 1.00–2.28) and malignancy (HR 1.53, 95% CI 1.11–2.12) compared with the reference group.

Limitations

Limitations include potential diagnostic misclassification, unmeasured confounding, including corticosteroid exposure, and limited statistical power for rare outcomes. Competing mortality was not accounted for in the analyses.

Conclusions

Age at diagnosis is associated with differences in comorbidity risk among patients with bullous pemphigoid. These findings support age‐stratified follow‐up, particularly with attention to diabetes in younger patients.

Zitieren

APA

Nørfjand, S. B., Frølunde, A. S., Kibsgaard, L., Bech, R., & Vestergaard, C. (2026). Age‐Related Differences in Comorbidities Following Bullous Pemphigoid: A Nationwide Cohort Study. JEADV Clinical Practice. https://doi.org/10.1002/jvc2.70473

Vancouver

Nørfjand SB, Frølunde AS, Kibsgaard L, Bech R, Vestergaard C. Age‐Related Differences in Comorbidities Following Bullous Pemphigoid: A Nationwide Cohort Study. JEADV Clinical Practice. 2026. doi:10.1002/jvc2.70473

BibTeX
@article{Nrfjand2026,
  author = {Nørfjand, Sille Brændsgaard and Frølunde, Anne Sofie and Kibsgaard, Line and Bech, Rikke and Vestergaard, Christian},
  title = {Age‐Related Differences in Comorbidities Following Bullous Pemphigoid: A Nationwide Cohort Study},
  journal = {JEADV Clinical Practice},
  year = {2026},
  doi = {10.1002/jvc2.70473}
}
Kostenlos starten →